These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32419232)

  • 1. Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
    Zhao N; Guo Y; He Y; Chen Y; Xing J
    J Clin Lab Anal; 2020 Aug; 34(8):e23354. PubMed ID: 32419232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eukaryotic translation initiation factor 3B is overexpressed and correlates with deteriorated tumor features and unfavorable survival profiles in cervical cancer patients.
    Zhu P; Tan Q; Jiang W; Ou Y; Xu P; Yuan L
    Cancer Biomark; 2019; 26(2):123-130. PubMed ID: 31322539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of eukaryotic translation initiation factor 3B and its correlation with tumor characteristics as well as prognosis in non-small cell lung cancer patients: a retrospective study.
    Liu C; Li X; Tian J; Zhang S; Liu Y; Zhai X; Feng Q
    J BUON; 2020; 25(5):2350-2357. PubMed ID: 33277855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EIF3B correlates with advanced disease stages and poor prognosis, and it promotes proliferation and inhibits apoptosis in non-small cell lung cancer.
    Tian Y; Zhao K; Yuan L; Li J; Feng S; Feng Y; Fang Z; Li H; Deng R
    Cancer Biomark; 2018; 23(2):291-300. PubMed ID: 30198870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
    Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor Forkhead Box Q1 Is Elevated, Correlates with Increased Tumor Size, International Federation of Gynecology and Obstetrics Stage but Worse Overall Survival in Epithelial Ovarian Cancer Patients.
    Wang X; Zhu X
    Cancer Biother Radiopharm; 2022 Nov; 37(9):837-842. PubMed ID: 33761267
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
    Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
    Biotechnol Appl Biochem; 2024 Aug; 71(4):733-740. PubMed ID: 38494670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes and prognostic factors of patients with epithelial ovarian cancer subjected to first-line treatment: a retrospective study of 251 cases.
    Fu Y; Wang X; Pan Z; Xie X
    Front Med; 2014 Mar; 8(1):91-5. PubMed ID: 24370920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
    Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
    Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of EIF3B gene downregulation on apoptosis and proliferation of human ovarian cancer SKOV3 and HO-8910 cells.
    Wang L; Ouyang L
    Biomed Pharmacother; 2019 Jan; 109():831-837. PubMed ID: 30551537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.
    Gong Y; Wang D; Lin L; Dai J; Yu L
    Medicine (Baltimore); 2019 Nov; 98(46):e17896. PubMed ID: 31725636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Abdominal Wall Metastases on Prognosis in Epithelial Ovarian Cancer.
    Ataseven B; du Bois A; Harter P; Prader S; Grimm C; Kurzeder C; Schneider S; Heikaus S; Kahl A; Traut A; Heitz F
    Int J Gynecol Cancer; 2016 Nov; 26(9):1594-1600. PubMed ID: 27654263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
    Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
    Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ-ITCH correlates with small tumor size, decreased FIGO stage and prolonged overall survival, and it inhibits cells proliferation while promotes cells apoptosis in epithelial ovarian cancer.
    Luo L; Gao Y; Sun X
    Cancer Biomark; 2018; 23(4):505-513. PubMed ID: 30347599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer.
    Vázquez Rojo J; Vázquez Reguera J; Sánchez del Río A
    Rev Colomb Obstet Ginecol; 2024 Mar; 75(1):. PubMed ID: 39013201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.